My research list

Loading My Research List ...

Save my research

Don't lose any of your research. Fill out the form below and have your research list emailed to you.

Senior Associate

Michelle Dunlop

BCom LLB(Hons)


P+64 9 977 5325

M+64 21 302 751

Michelle Dunlop

Michelle is a senior associate in the firm’s commercial group. Michelle has experience in a wide range of commercial matters, with a focus on working with clients in the development, deployment and implementation of technology solutions including artificial intelligence and machine learning-based solutions.

Michelle regularly drafts and negotiates commercial documentation for technology transactions for both customers and suppliers, including for large-scale technology procurements, ‘as a service’ arrangements and commercial arrangements supporting M&A transactions.

Before joining Simpson Grierson, Michelle worked in-house for a leading AI technology company where she advised on a variety of contracting arrangements such as inbound services, hardware and software procurement, data licensing, R&D and strategic partnerships. She regularly counselled on open source software licensing issues, as well as regulatory and compliance issues affecting new and emerging technologies.

Michelle provides guidance on data protection and cybersecurity issues. She routinely advises clients on their collection and handling of personal information, ‘big data’ initiatives and privacy law compliance.

She works with clients across a number of industry sectors, with a particular interest in the cross-section between the technology and health sectors.

Examples of Work

  • Advising a leading technology company on its AI-related R&D collaborations with several high-profile academic and non-profit research institutions
  • Advising CSL Limited on the supply and distribution arrangements in connection with their acquisition of Novartis’ flu vaccines business
  • Advising Baxter on the separation of its biopharmaceutical business
  • Advising multinational pharmaceutical and medical technology companies on a wide range of procurement, distribution and regulatory matters